These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 36197088)

  • 1. The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation.
    Shilagardi K; Spear ED; Abraham R; Griffin DE; Michaelis S
    mBio; 2022 Oct; 13(5):e0254322. PubMed ID: 36197088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
    Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1.
    Han M; Pandey D
    Am J Respir Cell Mol Biol; 2021 Sep; 65(3):300-308. PubMed ID: 34003736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.
    Winstone H; Lista MJ; Reid AC; Bouton C; Pickering S; Galao RP; Kerridge C; Doores KJ; Swanson CM; Neil SJD
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33563656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.
    Rowland R; Brandariz-Nuñez A
    Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation.
    Rajah MM; Bernier A; Buchrieser J; Schwartz O
    J Mol Biol; 2022 Mar; 434(6):167280. PubMed ID: 34606831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
    Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
    mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion.
    Jocher G; Grass V; Tschirner SK; Riepler L; Breimann S; Kaya T; Oelsner M; Hamad MS; Hofmann LI; Blobel CP; Schmidt-Weber CB; Gokce O; Jakwerth CA; Trimpert J; Kimpel J; Pichlmair A; Lichtenthaler SF
    EMBO Rep; 2022 Jun; 23(6):e54305. PubMed ID: 35527514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion.
    Phillips JM; Gallagher T; Weiss SR
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spike protein mediated membrane fusion during SARS-CoV-2 infection.
    Li X; Yuan H; Li X; Wang H
    J Med Virol; 2023 Jan; 95(1):e28212. PubMed ID: 36224449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
    Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
    J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calpain-2 mediates SARS-CoV-2 entry via regulating ACE2 levels.
    Zeng Q; Antia A; Casorla-Perez LA; Puray-Chavez M; Kutluay SB; Ciorba MA; Ding S
    mBio; 2024 Mar; 15(3):e0228723. PubMed ID: 38349185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
    Mondal T; Shivange G; Habieb A; Tushir-Singh J
    Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
    Zhu Y; Yu D; Yan H; Chong H; He Y
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Coronavirus Entry
    Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syncytia formation by SARS-CoV-2-infected cells.
    Buchrieser J; Dufloo J; Hubert M; Monel B; Planas D; Rajah MM; Planchais C; Porrot F; Guivel-Benhassine F; Van der Werf S; Casartelli N; Mouquet H; Bruel T; Schwartz O
    EMBO J; 2020 Dec; 39(23):e106267. PubMed ID: 33051876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.